Proinflammatory cytokines mediating burn-injury pain

Pain

Volumn 135, Issue 1-2, 2008, Pages 98-107

  Summer, Gretchen J ^a   Romero Sandoval, Edgar Alfonso ^d   Bogen, Oliver ^b   Dina, Olayinka A ^b   Khasar, Sachia G ^b   Levine, Jon D ^a,b,c  

^a University of Californias   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Dorsal root ganglia (DRG) nociceptor; gp130; IL 6; Interleukin (IL) 1 ; Mechanical hyperalgesia; Pain; Thermal injury; Tumor necrosis factor

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; OLIGODEOXYNUCLEOTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BURNS; CYTOKINES; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; HYPERALGESIA; INJECTIONS, SPINAL; INTERLEUKIN-6; MALE; MORPHOLINES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SKIN;

EID: 38749107032     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2007.05.012     Document Type: Article

References (67)

1. Allgöwer M., Schoenenberger G.A., and Sparkes B.G. Burning the largest immune organ. Burns 21 (1995) S7-S47
2. Ashburn M.A. Burn pain: the management of procedure-related pain. J Burn Care Rehabil 16 (1995) 365-371
3. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 (1994) 74-80
4. Bellido T., Borba V.Z., Roberson P., and Manolagas S.C. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138 (1997) 3666-3676
5. Byers J.F., Bridges S., Kijek J., and LaBorde P. Burn patients' pain and anxiety experiences. J Burn Care Rehabil 22 (2001) 144-149
6. Castell J.V., Gómez-Lechón M.J., David M., Fabra R., Trullenque R., and Heinrich P.C. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12 (1990) 1179-1186
7. Choinière M. Burn pain: a unique challenge. Pain: Clinical Updates IX (2001) 1-4
8. Choinière M., Melzack R., Rondeau J., Girard N., and Paquin M.J. The pain of burns: characteristics and correlates. J Trauma 29 (1989) 1531-1539
9. Cunha T.M., Verri Jr. W.A., Silva J.S., Poole S., Cunha F.Q., and Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 102 (2005) 1755-1760
10. Cunha T.M., Verri Jr. W.A., Vivancos G.G., Moreira I.F., Reis S., Parada C.A., et al. An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37 (2004) 401-407
11. de Bandt J.P., Chollet-Martin S., Hernvann A., Lioret N., du Roure L.D., Lim S.K., et al. Cytokine response to burn injury: relationship with protein metabolism. J Trauma 36 (1994) 624-628
12. Demling R.H. The clinical relevance of defining the mechanism for altered gut permeability in a "two-hit" model of injury and infection. Crit Care Med 32 (2004) 2356-2357
13. Dina O.A., Hucho T., Yeh J., Malik-Hall M., Reichling D.B., and Levine J.D. Primary afferent second messenger cascades interact with specific integrin subunits in producing inflammatory hyperalgesia. Pain 115 (2005) 191-203
14. Dina O.A., Messing R.O., and Levine J.D. Ethanol withdrawal induces hyperalgesia mediated by PKC epsilon. Eur J Neurosci 24 (2006) 197-204
15. Dina O.A., Parada C.A., Yeh J., Chen X., McCarter G.C., and Levine J.D. Integrin signaling in inflammatory and neuropathic pain in the rat. Eur J Neurosci 19 (2004) 634-642
16. Dong Z.-Q., Wang Y.-Q., Ma F., Xie H., and Wu G.-C. Down-regulation of GFRalpha-1 expression by antisense oligodeoxynucleotide aggravates thermal hyperalgesia in a rat model of neuropathic pain. Neuropharmacology 50 (2006) 393-403
17. Drost A.C., Burleson D.G., Cioffi Jr. W.G., Jordan B.S., Mason Jr. A.D., and Pruitt Jr. B.A. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 35 (1993) 335-339
18. Fey G.H., and Fuller G.M. Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 4 (1987) 323-338
19. Foertsch C.E., O'Hara M.W., Stoddard F.J., and Kealey G.P. Treatment-resistant pain and distress during pediatric burn-dressing changes. J Burn Care Rehabil 19 (1998) 219-224
20. Gibran N.S., and Heimbach D.M. Current status of burn wound pathophysiology. Clin Plast Surg 27 (2000) 11-22
21. Hedderich R., and Ness T.J. Analgesia for trauma and burns. Crit Care Clin 15 (1999) 167-184
22. Heinrich P.C., Behrmann I., Müller-Newen G., Schaper F., and Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334 (1998) 297-314
23. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem J 265 (1990) 621-636
24. Honari S., Patterson D.R., Gibbons J., Martin-Herz S.P., Mann R., Gibran N.S., et al. Comparison of pain control medication in three age groups of elderly patients. J Burn Care Rehabil 18 (1997) 500-504
25. Hulse R.E., Kunkler P.E., Fedynyshyn J.P., and Kraig R.P. Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J Neurosci Methods 136 (2004) 87-98
26. Humphries Y., Melson M., and Gore D. Superiority of oral ketamine as an analgesic and sedative for wound care procedures in the pediatric patient with burns. J Burn Care Rehabil 18 (1997) 34-36
27. Igwe O.J. Agents that act by different mechanisms modulate the activity of protein kinase CbetaII isozyme in the rat spinal cord during peripheral inflammation. Neuroscience 138 (2006) 313-328
28. Jostock T., Müllberg J., Ozbek S., Atreya R., Blinn G., Voltz N., et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268 (2001) 160-167
29. Kataranovski M., Magic Z., and Pejnovic N. Early inflammatory cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res 48 (1999) 473-482
30. Kawakami M., Kaneko N., Anada H., Terai C., and Okada Y. Measurement of interleukin-6, interleukin-10, and tumor necrosis factor-alpha levels in tissues and plasma after thermal injury in mice. Surgery 121 (1997) 440-448
31. Kerstens H.M., Poddighe P.J., and Hanselaar A.G. A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 43 (1995) 347-352
32. Khan S.S., Smith M.S., Reda D., Suffredini A.F., and McCoy Jr. J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 61 (2004) 35-39
33. Khasar S.G., Dina O.A., Green P.G., and Levine J.D. Estrogen regulates adrenal medullary function producing sexual dimorphism in nociceptive threshold and beta-adrenergic receptor-mediated hyperalgesia in the rat. Eur J Neurosci 21 (2005) 3379-3386
34. Kishimoto T., Akira S., Narazaki M., and Taga T. Interleukin-6 family of cytokines and gp130. Blood 86 (1995) 1243-1254
35. Kishimoto T., Akira S., and Taga T. IL-6 receptor and mechanism of signal transduction. Int J Immunopharmacol 14 (1992) 431-438
36. Kishimoto T., Akira S., and Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258 (1992) 593-597
37. Kishimoto T., Taga T., and Akira S. Cytokine signal transduction. Cell 76 (1994) 253-262
38. Kowal-Vern A., Sharp-Pucci M.M., Walenga J.M., Dries D.J., and Gamelli R.L. Trauma and thermal injury: comparison of hemostatic and cytokine changes in the acute phase of injury. J Trauma 44 (1998) 325-329
39. Kunkler P.E., Hulse R.E., and Kraig R.P. Multiplexed cytokine protein expression profiles from spreading depression in hippocampal organotypic cultures. J Cereb Blood Flow Metab 24 (2004) 829-839
40. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 389 (1982) 39-48
41. Ljunghusen O., Lundahl J., Nettelblad H., Nilsson B., Sjögren F., and Stendahl O. Endotoxemia and complement activation after severe burn injuries - effects on leukocytes, soluble selectins, and inflammatory cytokines. Inflammation 20 (1996) 229-241
42. Marano M.A., Fong Y., Moldawer L.L., Wei H., Calvano S.E., Tracey K.J., et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 170 (1990) 32-38
43. Munster A.M. The immunological response and strategies for intervention. Total Burn Care (2002) 316-330
44. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260 (1993) 1808-1810
45. Nijsten M.W., Hack C.E., Helle M., ten Duis H.J., Klasen H.J., and Aarden L.A. Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 109 (1991) 761-767
46. Nozaki-Taguchi N., and Yaksh T.L. A novel model of primary and secondary hyperalgesia after mild thermal injury in the rat. Neurosci Lett 254 (1998) 25-28
47. Papir-Kricheli D., Frey J., Laufer R., Gilon C., Chorev M., Selinger Z., et al. Behavioural effects of receptor-specific substance P agonists. Pain 31 (1987) 263-276
48. Parada C.A., Yeh J.J., Joseph E.K., and Levine J.D. Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci 17 (2003) 1847-1852
49. Patterson D.R., Ptacek J.T., Carrougher G.J., and Sharar S.R. Lorazepam as an adjunct to opioid analgesics in the treatment of burn pain. Pain 72 (1997) 367-374
50. Perry S., Heidrich G., and Ramos E. Assessment of pain by burn patients. J Burn Care Rehabil 2 (1981) 322-326
51. Peter F.W., Schuschke D.A., Barker J.H., Fleishcher-Peter B., Pierangeli S., Vogt P.M., et al. The effect of severe burn injury on proinflammatory cytokines and leukocyte behavior: its modulation with granulocyte colony-stimulating factor. Burns 25 (1999) 477-486
52. Ptacek J.T., Patterson D.R., and Doctor J. Describing and predicting the nature of procedural pain after thermal injuries: implications for research. J Burn Care Rehabil 21 (2000) 318-326
53. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111 (1957) 409-419
54. Sakallioglu A.E., Basaran O., Karakayali H., Ozdemir B.H., Yucel M., Arat Z., et al. Interactions of systemic immune response and local wound healing in different burn depths: an experimental study on rats. J Burn Care Res 27 (2006) 357-366
55. Schwacha M.G. Macrophages and post-burn immune dysfunction. Burns 29 (2003) 1-14
56. Sharar S.R., Bratton S.L., Carrougher G.J., Edwards W.T., Summer G., Levy F.H., et al. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil 19 (1998) 516-521
57. Summer G.J., Puntillo K.A., Miaskowski C., Dina O.A., Green P.G., and Levine J.D. TrkA and PKC-epsilon in thermal burn-induced mechanical hyperalgesia in the rat. J Pain 7 (2006) 884-891
58. Taga T. The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. Ann Med 29 (1997) 63-72
59. Vermes C., Jacobs J.J., Zhang J., Firneisz G., Roebuck K.A., and Glant T.T. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 277 (2002) 16879-16887
60. Vivancos G.G., Verri Jr. W.A., Cunha T.M., Schivo I.R.S., Parada C.A., Cunha F.Q., et al. An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res 37 (2004) 391-399
61. Wang Y., Nesbitt J.E., Fuentes N.L., and Fuller G.M. Molecular cloning and characterization of the rat liver IL-6 signal transducing molecule, gp130. Genomics 14 (1992) 666-672
62. Wang Y.Y., Wu S.X., Zhou L., Huang J., Wang W., Liu X.Y., et al. Dose-related antiallodynic effects of cyclic AMP response element-binding protein-antisense oligonucleotide in the spared nerve injury model of neuropathic pain. Neuroscience 139 (2006) 1083-1093
63. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., and Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res 654 (1994) 15-26
64. Weddell R. Improving pain management for patients in a hospital burns unit. Nurs Times 100 (2004) 38-40
65. Weinberg K., Birdsall C., Vail D., Marano M.A., Petrone S.J., and Mansour E.H. Pain and anxiety with burn dressing changes: patient self-report. J Burn Care Rehabil 21 (2000) 155-156 [discussion 157-161]
66. Yoshizaki K., Nishimoto N., Matsumoto K., Tagoh H., Taga T., Deguchi Y., et al. Interleukin 6 and expression of its receptor on epidermal keratinocytes. Cytokine 2 (1990) 381-387
67. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110